As GLP-1RAs have gained popularity, some cases involving rarer adverse effects have been reported in recent literature
Therapeutic efficacy of liraglutide versus metformin in modulating the gut microbiota for treating type 2 diabetes mellitus complicated with nonalcoholic fatty liver disease
S., Lohana, D., Kumar, P., Nandula, S
placebo in adults with overweight or obesity without diabetes (STEP 3), mean body weight decreased 16.0% with semaglutide compared with 5.7% with placebo, both as adjunct to intensive behavioral therapy (ETD 10.3%
DiMarchi suspects that the GLP-1 might have reduced damaging inflammation in her brain from her postconcussion syndrome, which played a role in her turnaround